Pilot-scale production of therapeutically-active cannabinoids

具有治疗活性的大麻素的中试规模生产

• 批准号: LP160101317
• 负责人: A/Prof Monika Doblin
• 金额: $ 32.88万
• 依托单位: La Trobe University
• 依托单位国家: 澳大利亚
• 项目类别: Linkage Projects
• 财政年份: 2018
• 资助国家: 澳大利亚
• 起止时间: 2018-11-12 至 2021-12-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/LP160101317
• 关键词: Pilot; scale; production; therapeutically; active

The Isolation of minor therapeutically-active cannabinoids from cannabis at pilot scale would establish a commercially competitive Australian industry and lead to a superior position in the global marketplace. This project aims to select elite clones from genetically diverse cannabis strains for yield of minor, but therapeutically-active, cannabinoids, and develop a pilot-scale extraction and separation procedure that can be scaled-up for commercial production. This would contribute to the growth of the agri-biotechnology sector and a skilled multidisciplinary workforce in rural Australia, thus providing significant economic benefit. The novel scale-up procedure has potential for industry adoption to add value to Australian manufacturing.

中试规模从大麻中分离出具有治疗活性的次要大麻素将建立具有商业竞争力的澳大利亚产业，并在全球市场上占据优势地位。该项目旨在从基因多样化的大麻菌株中选择精英克隆，以生产少量但具有治疗活性的大麻素，并开发可扩大规模用于商业生产的中试规模提取和分离程序。这将有助于澳大利亚农村农业生物技术部门和熟练的多学科劳动力的发展，从而带来显着的经济效益。这种新颖的扩大规模程序有可能被行业采用，从而为澳大利亚制造业增加价值。